BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36413921)

  • 21. Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan.
    Ng TC; Cheng HY; Chang HH; Liu CC; Yang CC; Jian SW; Liu DP; Cohen T; Lin HH
    JAMA Intern Med; 2021 Jul; 181(7):913-921. PubMed ID: 33821922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 in Japan, January-March 2020: insights from the first three months of the epidemic.
    Imai N; Gaythorpe KAM; Bhatia S; Mangal TD; Cuomo-Dannenburg G; Unwin HJT; Jauneikaite E; Ferguson NM
    BMC Infect Dis; 2022 May; 22(1):493. PubMed ID: 35614394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved time-varying reproduction numbers using the generation interval for COVID-19.
    Kim T; Lee H; Kim S; Kim C; Son H; Lee S
    Front Public Health; 2023; 11():1185854. PubMed ID: 37457248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Serial Interval Variation, Montana, USA, March 1-July 31, 2020.
    Reed IG; Walker ES; Landguth EL
    Emerg Infect Dis; 2021 May; 27(5):1486-1491. PubMed ID: 33900189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.
    Nakajo K; Nishiura H
    Theor Biol Med Model; 2021 Jul; 18(1):12. PubMed ID: 34271962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    Buitrago-Garcia D; Ipekci AM; Heron L; Imeri H; Araujo-Chaveron L; Arevalo-Rodriguez I; Ciapponi A; Cevik M; Hauser A; Alam MI; Meili K; Meyerowitz EA; Prajapati N; Qiu X; Richterman A; Robles-Rodriguez WG; Thapa S; Zhelyazkov I; Salanti G; Low N
    PLoS Med; 2022 May; 19(5):e1003987. PubMed ID: 35617363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Maeda H; Saito N; Igarashi A; Ishida M; Suami K; Yagiuchi A; Kimura Y; Komino M; Arai H; Morikawa T; Motohashi I; Miyazawa R; Moriyama T; Kamura H; Terada M; Kuwamitsu O; Hayakawa T; Sando E; Ohara Y; Teshigahara O; Suzuki M; Morimoto K
    Clin Infect Dis; 2022 Nov; 75(11):1971-1979. PubMed ID: 35438137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia.
    Althobaity Y; Wu J; Tildesley MJ
    Infect Dis Model; 2022 Sep; 7(3):473-485. PubMed ID: 35938094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of the serial interval and proportion of pre-symptomatic transmission events of COVID- 19 in Ireland using contact tracing data.
    McAloon CG; Wall P; Griffin J; Casey M; Barber A; Codd M; Gormley E; Butler F; McV Messam LL; Walsh C; Teljeur C; Smyth B; Nolan P; Green MJ; O'Grady L; Culhane K; Buckley C; Carroll C; Doyle S; Martin J; More SJ
    BMC Public Health; 2021 Apr; 21(1):805. PubMed ID: 33906635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
    Sugano N; Ando W; Fukushima W
    J Infect Dis; 2020 Oct; 222(10):1635-1640. PubMed ID: 32840606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing Asymptomatic, Presymptomatic, and Symptomatic Transmission Risk of Severe Acute Respiratory Syndrome Coronavirus 2.
    Wu P; Liu F; Chang Z; Lin Y; Ren M; Zheng C; Li Y; Peng Z; Qin Y; Yu J; Geng M; Yang X; Zhao H; Li Z; Zhou S; Ran L; Cowling BJ; Lai S; Chen Q; Wang L; Tsang TK; Li Z
    Clin Infect Dis; 2021 Sep; 73(6):e1314-e1320. PubMed ID: 33772573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
    Marks M; Millat-Martinez P; Ouchi D; Roberts CH; Alemany A; Corbacho-Monné M; Ubals M; Tobias A; Tebé C; Ballana E; Bassat Q; Baro B; Vall-Mayans M; G-Beiras C; Prat N; Ara J; Clotet B; Mitjà O
    Lancet Infect Dis; 2021 May; 21(5):629-636. PubMed ID: 33545090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.
    Kang M; Xin H; Yuan J; Ali ST; Liang Z; Zhang J; Hu T; Lau EH; Zhang Y; Zhang M; Cowling BJ; Li Y; Wu P
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of cross-border-associated cases on the SARS-CoV-2 epidemic in Switzerland during summer 2020 and 2021.
    Reichmuth ML; Hodcroft EB; Riou J; Neher RA; Hens N; Althaus CL
    Epidemics; 2022 Dec; 41():100654. PubMed ID: 36444785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint Estimation of Generation Time and Incubation Period for Coronavirus Disease 2019.
    Lau YC; Tsang TK; Kennedy-Shaffer L; Kahn R; Lau EHY; Chen D; Wong JY; Ali ST; Wu P; Cowling BJ
    J Infect Dis; 2021 Nov; 224(10):1664-1671. PubMed ID: 34423821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferring time-varying generation time, serial interval, and incubation period distributions for COVID-19.
    Chen D; Lau YC; Xu XK; Wang L; Du Z; Tsang TK; Wu P; Lau EHY; Wallinga J; Cowling BJ; Ali ST
    Nat Commun; 2022 Dec; 13(1):7727. PubMed ID: 36513688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics.
    Harris JD; Park SW; Dushoff J; Weitz JS
    Epidemics; 2023 Mar; 42():100664. PubMed ID: 36706626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal dynamics in viral shedding and transmissibility of COVID-19.
    He X; Lau EHY; Wu P; Deng X; Wang J; Hao X; Lau YC; Wong JY; Guan Y; Tan X; Mo X; Chen Y; Liao B; Chen W; Hu F; Zhang Q; Zhong M; Wu Y; Zhao L; Zhang F; Cowling BJ; Li F; Leung GM
    Nat Med; 2020 May; 26(5):672-675. PubMed ID: 32296168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.